We investigated the signals downstream from FGFR3 responsible for the observed higher levels of MYC mRNA and greater MYC protein stability in bladder cancer cells harboring FGFR3 mutations (Fig 1). The gene discussed is MYC; the disease is urinary bladder cancer.